Neurocrine Biosciences NBIX
NASDAQ NBIX
$174.41 +5.27 (+3.12%)
At close: Nov 11, 2026 · 4:00 PM EST

Neurocrine Biosciences (NBIX) Selling, General & Administrative (2009 - 2026)

Updated

Analysis

Neurocrine Biosciences (NBIX) Selling, General & Administrative (2009 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 3.13 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 6.29 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 4.09 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.89 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 5.11 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 1.68 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 1.64 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 3.28 Bn
10 Neurocrine Biosciences 17.13 Bn 13.21 Bn 1.10 Bn 366.30 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 366.30 Mn
Jun 30, 2026 439.70 Mn
Mar 31, 2026 318.50 Mn
Dec 31, 2025 301.80 Mn
Sep 30, 2025 291.60 Mn
Jun 30, 2025 286.30 Mn
Mar 31, 2025 276.50 Mn
Dec 31, 2024 287.80 Mn
Sep 30, 2024 234.30 Mn
Jun 30, 2024 242.00 Mn
Mar 31, 2024 243.10 Mn
Dec 31, 2023 218.90 Mn
Sep 30, 2023 204.20 Mn
Jun 30, 2023 221.80 Mn
Mar 31, 2023 242.70 Mn
Dec 31, 2022 182.90 Mn
Sep 30, 2022 186.30 Mn
Jun 30, 2022 182.80 Mn
Mar 31, 2022 200.70 Mn
Dec 31, 2021 156.50 Mn
API Access

Neurocrine Biosciences Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=NBIX&period=max&api_key=YOUR_API_KEY